title: Can a K103N HIV strain stably overcome the wild type in the absence of non-nucleoside reverse transcriptase inhibitor selective pressure?
authors.forename: Amedeo F
authors.initials: AF
authors.lastname: Capetti
authors.forename: Alexandra I
authors.initials: AI
authors.lastname: Gabris
authors.forename: Lorenzo
authors.initials: L
authors.lastname: Drago
authors.forename: Gian Marco
authors.initials: GM
authors.lastname: Vigevani
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use*; D024882:Drug Resistance, Viral; D005260:Female; D015658:HIV Infections / Q000188:drug therapy / Q000235:genetics*; D015497:HIV-1 / Q000235:genetics*; D006801:Humans; D008875:Middle Aged; D009154:Mutation / Q000235:genetics*; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D012641:Selection, Genetic
chemical_list: D019380:Anti-HIV Agents; D018894:Reverse Transcriptase Inhibitors